PLoS ONE (Jan 2023)
Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0233499.].
PLoS ONE (Jan 2023)
[This corrects the article DOI: 10.1371/journal.pone.0233499.].